A nontandem novel compound chimeric antigen receptor redirected to target CD20-CD19 positive B-cell acute leukemias and B-cell lymphoma

Simple item page
dc.contributor.authorDeStefano, Vincent M.
dc.contributor.authorWada, Masayuki
dc.contributor.authorPinz, Kevin G.
dc.contributor.authorAssi, Rita
dc.contributor.authorZhang, Hongyu
dc.contributor.authorWang, Weijia
dc.contributor.authorZhang, Wenli
dc.contributor.authorShah, Darshi
dc.contributor.authorMa, Yupo
dc.contributor.authorSalman, Huda
dc.contributor.departmentMedicine, School of Medicine
dc.date.accessioned2024-09-16T10:47:14Z
dc.date.available2024-09-16T10:47:14Z
dc.date.issued2024
dc.eprint.versionFinal published version
dc.identifier.citationDeStefano VM, Wada M, Pinz KG, et al. A nontandem novel compound chimeric antigen receptor redirected to target CD20-CD19 positive B-cell acute leukemias and B-cell lymphoma. Clin Transl Med. 2024;14(7):e1743. doi:10.1002/ctm2.1743
dc.identifier.urihttps://hdl.handle.net/1805/43321
dc.language.isoen_US
dc.publisherWiley
dc.relation.isversionof10.1002/ctm2.1743
dc.relation.journalClinical and Translational Medicine
dc.rightsAttribution 4.0 Internationalen
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourcePMC
dc.subjectB-Cell Lymphoma
dc.subjectCD19 Antigens
dc.subjectCD29 Antigens
dc.titleA nontandem novel compound chimeric antigen receptor redirected to target CD20-CD19 positive B-cell acute leukemias and B-cell lymphoma
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
DeStefano2024Nontandem-CCBY.pdf
Size:
4.64 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
2.04 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Medicine Works